Matthew Mazdyasni
Director · Astrana Health, Inc.
Individual
- 2025
- Jun 12, 2026
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Matthew Mazdyasni's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Peter Beck - $429.59M in RKLB purchases and sales in the last 12 months
- AEROEQUITY GP, LLC - $384.00M in FLY purchases and sales in the last 12 months
- Jonathan B. Fairbanks - $355.10M in FLOC purchases and sales in the last 12 months
- GIC Private Ltd - $332.55M in SARO purchases and sales in the last 12 months
- Amberjack Capital Partners, L.P. - $306.16M in INVX purchases and sales in the last 12 months
- INNOVEX CO-INVEST FUND, L.P. - $306.16M in INVX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew Mazdyasni?
Matthew Mazdyasni is a corporate insider, tracked as Director of Astrana Health, Inc. (ASTH). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Matthew Mazdyasni last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 3 filings going back to 2025.
